Huntington disease (HD) is a neurodegenerative disorder caused by an elongated polyglutamine tract in huntingtin (htt). Htt normally undergoes different posttranslational modifications (PTMs), including phosphorylation, SUMOylation, ubiquitination, acetylation, proteolytic cleavage and palmitoylation. In the presence of the HD mutation, some PTMs are significantly altered and can result in changes in the clinical phenotype. A rate limiting PTM is defined as one which can result in significant effects on the phenotype in animal models. For example the prevention of proteolysis at D586 as well as constitutive phosphorylation at S13 and S16 can obviate the expression of phenotypic features of HD. The enzymes involved in these modifications such as caspase-6, the IκB kinase (IKK) complex and still to be characterized phosphatases therefore represent promising therapeutic targets for HD. Identifying and testing specific modulators of PTMs now constitutes the next big challenge in order to further validate these targets and proceed towards the goal of a mechanism-based treatment for HD.
Huntington disease: one mutation, multiple pathwaysHtt is a 350 kDa protein which when mutated by an elongated polyglutamine (polyglutamine) tract (>35) causes HD, which manifests with symptoms that include personality changes, involuntary movement and intellectual decline usually in midadulthood (Novak and Tabrizi 2010). On a cellular level, HD is characterized by neuronal dysfunction initially followed by the loss of medium spiny neurons in the striatum and subsequent more wide-spread damage (Albin and others 1990).Even though its mutant form causes predominantly brain pathology, htt is ubiquitously expressed within and outside the nervous system (Strong and others 1993) and is present in different subcellular compartments including the nucleus, the Golgi complex, mitochondria, microtubules and vesicular structures in neurites and at synapses (Caviston, Ross, Antony, Tokito and Holzbaur 2007;Choo, Johnson, MacDonald, Detloff and Lesort 2004;Hoffner, Kahlem and Djian 2002; Kang and others 2007;McGuire, Rong, Li and Li 2006;Strehlow, Li and Myers 2007). A large variety of htt-interacting proteins have been described with a multitude of functions ranging from endocytosis and vesicle transport to cell signalling, apoptosis and transcriptional regulation. Htt acts as a scaffolding protein bringing together its interaction partners and allowing them to transfer information between cellular compartments (Harjes and Wanker 2003), PTMs are postulated to play a major role in the flexibility of htt's protein-protein interactions and to influence its subcellular localization.
Htt protein structure and localization of PTMsThe human Htt protein ( Fig. 1) has a polymorphic glutamine stretch at the N-terminus, adjacent to a proline-rich region which is an important mediator of protein-protein interactions, may regulate turnover of the htt protein and keep the protein in a non- (Bhattacharyya and others 2006;Dehay and Bertolotti 2006; South...